<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02766244</url>
  </required_header>
  <id_info>
    <org_study_id>003 NCT02028520</org_study_id>
    <nct_id>NCT02766244</nct_id>
    <nct_alias>NCT02028520</nct_alias>
  </id_info>
  <brief_title>Indocyanine Green (ICG) and SPY Imaging for Assessment of Burn Healing</brief_title>
  <official_title>Indocyanine Green (ICG) and SPY Imaging for Assessment of Burn Healing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Texas Tech University Health Sciences Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Texas Tech University Health Sciences Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Three patients were recruited for assessment of ICG fluorescence in burns.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The early determination of healing potential in indeterminate thickness burns may be
      difficult to establish by visual inspection alone, even for experienced burn practitioners.
      This case series explores the use of indocyanine green (ICG) fluorescence using portable
      bedside assessment as a potential tool for early determination of burn depth. Three subjects
      with indeterminate thickness burns had daily perfusion assessment using ICG fluorescence
      assessment using the SPY machine (SPYÂ®, Lifecell Corp., NJ, USA) in addition to standard burn
      care. The fluorescence was quantified as a percentage of the perfusion of intact skin, and
      areas of hypo and hyper-perfusion were indicated. The burn surgeon, blinded to the ICG
      results, made a clinical determination of the need for skin grafting or discharge. The
      perfusion in areas of differing depth of burn were compared over the entire study period to
      determine both the magnitude of difference, and the point in the time course of healing when
      these changes became evident.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2014</start_date>
  <completion_date type="Actual">July 2014</completion_date>
  <primary_completion_date type="Actual">July 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Perfusion of Burned Area</measure>
    <time_frame>5 days</time_frame>
    <description>Perfusion as measured by ICG Fluorescence</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">3</enrollment>
  <condition>Burns</condition>
  <arm_group>
    <arm_group_label>ICG/SPY</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Daily wound care with antibiotic ointments after cleansing plus evaluation using ICG/SPY fluorescence.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ICG/SPY</intervention_name>
    <description>indocyanine green fluorescence imaging</description>
    <arm_group_label>ICG/SPY</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Antibiotic Ointment</intervention_name>
    <description>Antibiotic ointment</description>
    <arm_group_label>ICG/SPY</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with burn less than 15% TBSA

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>89 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <results_reference>
    <citation>Dissanaike S, Abdul-Hamed S, Griswold JA. Variations in burn perfusion over time as measured by portable ICG fluorescence: A case series. Burns Trauma. 2014 Oct 25;2(4):201-5. doi: 10.4103/2321-3868.142397. eCollection 2014.</citation>
    <PMID>27602383</PMID>
  </results_reference>
  <verification_date>June 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 13, 2015</study_first_submitted>
  <study_first_submitted_qc>May 5, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 9, 2016</study_first_posted>
  <results_first_submitted>June 16, 2016</results_first_submitted>
  <results_first_submitted_qc>June 16, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 17, 2016</results_first_posted>
  <last_update_submitted>June 16, 2016</last_update_submitted>
  <last_update_submitted_qc>June 16, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 17, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Texas Tech University Health Sciences Center</investigator_affiliation>
    <investigator_full_name>Sharmila Dissanaike</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Burns</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>ICG/SPY</title>
          <description>Daily wound care with antibiotic ointments after cleansing plus evaluation using ICG/SPY fluorescence.
ICG/SPY: indocyanine green fluorescence imaging
Antibiotic Ointment: Antibiotic ointment</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ICG/SPY</title>
          <description>Daily wound care with antibiotic ointments after cleansing plus evaluation using ICG/SPY fluorescence.
ICG/SPY: indocyanine green fluorescence imaging
Antibiotic Ointment: Antibiotic ointment</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="3"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Size of burn</title>
          <units>% of body surface area</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7" lower_limit="7" upper_limit="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Perfusion of Burned Area</title>
        <description>Perfusion as measured by ICG Fluorescence</description>
        <time_frame>5 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Patient 1 Superficial</title>
            <description>Daily wound care with antibiotic ointments after cleansing plus evaluation using ICG/SPY fluorescence.
ICG/SPY: indocyanine green fluorescence imaging
Antibiotic Ointment: Antibiotic ointment</description>
          </group>
          <group group_id="O2">
            <title>Patient 1 Deep Tissue</title>
            <description>Daily wound care with antibiotic ointments after cleansing plus evaluation using ICG/SPY fluorescence.
ICG/SPY: indocyanine green fluorescence imaging
Antibiotic Ointment: Antibiotic ointment</description>
          </group>
          <group group_id="O3">
            <title>Patient 2 Superficial</title>
            <description>Daily wound care with antibiotic ointments after cleansing plus evaluation using ICG/SPY fluorescence.
ICG/SPY: indocyanine green fluorescence imaging
Antibiotic Ointment: Antibiotic ointment</description>
          </group>
          <group group_id="O4">
            <title>Patient 2 Deep Tissue</title>
            <description>Daily wound care with antibiotic ointments after cleansing plus evaluation using ICG/SPY fluorescence.
ICG/SPY: indocyanine green fluorescence imaging
Antibiotic Ointment: Antibiotic ointment</description>
          </group>
          <group group_id="O5">
            <title>Patient 3 Superficial</title>
            <description>Daily wound care with antibiotic ointments after cleansing plus evaluation using ICG/SPY fluorescence.
ICG/SPY: indocyanine green fluorescence imaging
Antibiotic Ointment: Antibiotic ointment</description>
          </group>
          <group group_id="O6">
            <title>Patient 3 Deep Tissue</title>
            <description>Daily wound care with antibiotic ointments after cleansing plus evaluation using ICG/SPY fluorescence.
ICG/SPY: indocyanine green fluorescence imaging
Antibiotic Ointment: Antibiotic ointment</description>
          </group>
        </group_list>
        <measure>
          <title>Perfusion of Burned Area</title>
          <description>Perfusion as measured by ICG Fluorescence</description>
          <units>% perfusion compared to normal skin</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="1"/>
                <count group_id="O3" value="1"/>
                <count group_id="O4" value="1"/>
                <count group_id="O5" value="1"/>
                <count group_id="O6" value="1"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Day 1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="200"/>
                    <measurement group_id="O2" value="100"/>
                    <measurement group_id="O3" value="205"/>
                    <measurement group_id="O4" value="180"/>
                    <measurement group_id="O5" value="205"/>
                    <measurement group_id="O6" value="110"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="300"/>
                    <measurement group_id="O2" value="200"/>
                    <measurement group_id="O3" value="210"/>
                    <measurement group_id="O4" value="110"/>
                    <measurement group_id="O5" value="180"/>
                    <measurement group_id="O6" value="190"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 3</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="250"/>
                    <measurement group_id="O2" value="180"/>
                    <measurement group_id="O3" value="280"/>
                    <measurement group_id="O4" value="200"/>
                    <measurement group_id="O5" value="500"/>
                    <measurement group_id="O6" value="380"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="180"/>
                    <measurement group_id="O2" value="100"/>
                    <measurement group_id="O3" value="470"/>
                    <measurement group_id="O4" value="250"/>
                    <measurement group_id="O5" value="200"/>
                    <measurement group_id="O6" value="150"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Day 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="205"/>
                    <measurement group_id="O2" value="140"/>
                    <measurement group_id="O3" value="NA">No data on this day</measurement>
                    <measurement group_id="O4" value="NA">No data on this day</measurement>
                    <measurement group_id="O5" value="NA">No data on this day</measurement>
                    <measurement group_id="O6" value="NA">No data on this day</measurement>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Three months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>ICG/SPY</title>
          <description>Daily wound care with antibiotic ointments after cleansing plus evaluation using ICG/SPY fluorescence.
ICG/SPY: indocyanine green fluorescence imaging
Antibiotic Ointment: Antibiotic ointment</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="3"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Sharmila Dissanaike</name_or_title>
      <organization>Texas Tech University Health Sciences Center</organization>
      <phone>8067435609</phone>
      <email>sharmila.dissanaike@ttuhsc.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

